Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Current Leases (2019 - 2022)

Aytu Biopharma (AYTU) has disclosed Current Leases for 3 consecutive years, with $940000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Current Leases rose 212.89% to $940000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $940000.0, a 212.89% increase, with the full-year FY2021 number at $940000.0, up 212.89% from a year prior.
  • Current Leases was $940000.0 for Q2 2021 at Aytu Biopharma, up from $100263.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $940000.0 in Q2 2021 to a low of $79362.0 in Q3 2019.
  • A 3-year average of $269928.9 and a median of $100263.0 in 2020 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: rose 21.16% in 2020, then skyrocketed 212.89% in 2021.
  • Aytu Biopharma's Current Leases stood at $82755.0 in 2019, then grew by 21.16% to $100263.0 in 2020, then soared by 837.53% to $940000.0 in 2021.
  • Per Business Quant, the three most recent readings for AYTU's Current Leases are $940000.0 (Q2 2021), $100263.0 (Q4 2020), and $97458.0 (Q3 2020).